3 cells per well) and incubated at 37°C, 5% CO 2 for 24 hours to allow attachment.
For preparation of multi-tumour spheroids SKOV3 tumour cells were trypsinised from monolayer cultures and cell suspensions seeded in 24-well, 1% agarose-coated plates, approximately 10,000 cells per well. Spheroids were grown at 37°C, 5% CO 2 for 7 days.
Apotosis (caspaseGlo3/7, Promega) and cell viability (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma)) assays were performed as described previously [11] .
Pharmacokinetics
The in-life portion of this study was performed at the GSK Clinical Imaging Centre, UK, and the mass spectrometry (MS) analysis of this study was carried out by GSK, 
